Cardiovascular Prevention as the Cornerstone of a Competitive Europe – Scaling Up Lipid Screening to Secure Next Generations
A Decade of Advocacy, A Future of Prevention
Ten years ago, FH Europe Foundation held its first-ever high-level event on familial hypercholesterolaemia (FH) paediatric screening in the European Parliament. It was a pioneering milestone that put inherited lipid disorders firmly on the political agenda. A decade later, the urgency remains the same: we can no longer wait.
That is why this meeting was more than a Parliament event; it’s a call to action. It built on the foundation laid by the Prague Declaration on FH Paediatric Screening and the Brussels Declaration on Lp(a) Testing and Management. It’s part of a movement that places inherited lipid conditions at the centre of cardiovascular prevention strategies, where they have always belonged.
The event was co-hosted by MEP Romana Jerković, Chair of the MEP Cardiovascular Health Group, and MEP Tomislav Sokol, Member of the SANT Committee on Public Health—underlining the strong political momentum to place early detection, screening, and personalised prevention at the heart of Europe’s health and competitiveness agenda.
We were proud to feature EAS President, Prof. Børge Nordestgaard, alongside Prof. Albert Wiegman (Netherlands) and Prof. Florian Kronenberg (Austria, online).
We now hope that the EU Cardiovascular Health Plan will be adopted, building on the momentum and commitment demonstrated at this event.
See below for the key take-away messages from the participants: